アジア太平洋地域放射性医薬品市場規模、シェア、競争環境、トレンド分析レポート：製品別（診断用、治療用）、タイプ別（ドップラーOCT、カテーテル、ハンドヘルド型、卓上型）、用途別（診断、治療）： 2025年から2033年までの機会分析および業界予測

レポートID : ROJP0425554 | 発行日 : 2025年04月 | フォーマット : : :

無料サンプル

試読申込

見積もり

Asia Pacific Radiopharmaceuticals Market Report - Table of Contents

1. INTRODUCTION

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1 Market Overview
4.2 Market Drivers
4.2.1 Growth in Demand for Radiopharmaceuticals in Diagnostics and Clinical Use Pushes the Market's Expansion
4.3 Market Restraints
4.3.1 Potential Risks Associated with Radiopharmaceuticals May Impede the Growth of the Market
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value- USD million)

5.1 By Product
5.1.1 Diagnostics
5.1.1.1 SPECT
5.1.1.2 PET
5.1.1.3 Therapeutics
5.1.1.4 Beta Emitters
5.1.1.5 Brachytherapy
5.1.1.6 Alpha Emitters
5.2.2 By Types
5.2.2.1 Doppler OCT
5.2.2.2 Catheter
5.2.2.3 Handheld
5.2.2.4 Tabletop
5.3.2 By Applications
5.3.2.1 Diagnostics
5.3.2.2 Neurology
5.3.2.3 Cardiology
5.3.2.4 Oncology
5.3.2.5.Lymphoma
5.3.2.6 Thyroid
5.3.2.7 Therapeutics
5.3.2.8. Bone Metastasis
5.3.2.9 Thyroid
5.3.2.10 Lymphoma
5.4.2.11 Endocrine Tumor
5.4 Geography
5.4.1 China
5.4.2 Japan
5.4.3 India
5.4.4 Australia
5.4.5 South Korea
5.4.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Nordion, Inc.
6.1.3 GE Healthcare
6.1.4 Bracco Group
6.1.5 Mallinckrodt Public Limited Company
6.1.6 IRE - IRE ELiT - BE
6.1.7 NTP
6.1.8 ANSTO
6.1.9 ECZACIBAŞI-MONROL
6.1.10 Lantheus
6.1.11 Eckert & Ziegler
6.1.12 Cardinal Health

7. MARKET OPPORTUNITIES AND FUTURE TRENDS